05/24/22 4:21 PMNasdaq : AEMD low float/C O R R E C T I O N -- Aethlon Medical, Inc./In the news release, Aethlon Medical to Present at the H.C. Wainwright Global Investment Conference, issued 17-May-2022 by Aethlon Medical, Inc. over PR Newswire, we are advised by the company that in the "Company Webcasting Link" section, the link should only be directing toRHEA-AIneutral
05/17/22 8:01 AMNasdaq : AEMD conferenceslow floatAethlon Medical to Present at the H.C. Wainwright Global Investment ConferenceAethlon Medical, Inc. (Nasdaq: AEMD), a medical technology company focused on developing products to diagnose and treat life and organ threatening diseases, today announced that it will be presenting at the H.C. Wainwright Global Investment Conference. TheRHEA-AIneutral
05/02/22 8:01 AMNasdaq : AEMD covid-19low floatAethlon Medical Publishes In Vitro Studies Demonstrating Hemopurifier Resin Binding of Seven Clinically Relevant COVID-19 VariantsAethlon Medical, Inc. (Nasdaq: AEMD), a medical technology company focused on developing products to diagnose and treat life and organ threatening diseases, today announcedRHEA-AIneutral
03/28/22 8:01 AMNasdaq : AEMD managementlow floatAethlon Medical, Inc. Appoints Angela Rossetti to Board of DirectorsAethlon Medical, Inc. ("Aethlon") (Nasdaq: AEMD), a medical technology company focused on developing products to diagnose and treat life and organ threatening diseases, today announced the appointment of Angela Rossetti to the Aethlon Board of Directors,RHEA-AIvery positive
02/14/22 4:15 PMNasdaq : AEMD earningslow floatAethlon Medical Announces Third Quarter Financial Results and Provides Corporate UpdateAethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious diseases, today reported financial results for its third quarter ended December 31, 2021 and provided an update on recentRHEA-AIneutral
01/31/22 8:01 AMNasdaq : AEMD earningslow floatAethlon Medical to Release Third Quarter Financial Results and Host Conference Call on February 14, 2022Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease, today announced that it will issue financial results for its third quarter fiscal year 2022, ended December 31, 2021, atRHEA-AIneutral
11/09/21 4:15 PMNasdaq : AEMD earningslow floatAethlon Medical Announces Second Quarter Financial Results and Provides Corporate UpdateAethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious diseases, today reported financial results for its second quarter ended September 30, 2021 and provided an update on recentRHEA-AIneutral
11/02/21 8:02 AMNasdaq : AEMD earningslow floatAethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 9, 2021Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease, today announced that it will issue financial results for its second quarter fiscal year 2022, ended September 30, 2021, atRHEA-AIneutral
10/12/21 8:01 AMNasdaq : AEMD covid-19low floatAethlon Medical Announces Peer-Reviewed Publication of Two Case Studies of Critically Ill COVID-19 Patients Treated with the Hemopurifier®Aethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease, today announced the publication of a manuscript in the peer-reviewed journal Frontiers in Medicine describing two cases ofRHEA-AIneutral
09/30/21 8:02 AMNasdaq : AEMD, PPD low floatAethlon Medical Announces Contracting with PPD to Advance Hemopurifier Clinical ProgramsAethlon Medical, Inc. (Nasdaq: AEMD), a company developing medical technology to treat cancer and life-threatening infectious disease, today announced that it has entered into an agreement with PPD, Inc. (Nasdaq: PPD), a leading global contract researchRHEA-AIneutral